EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Economic cost savings with the use of total body phototherapy for the treatment of severe neonatal jaundice in Nigeria

Onwe OE, Ezeanosike OB, Obu CD, Daniyan OW, Amadi HO

Journal of Pediatrics & Neonatal Care · 2019-12-16 · 9 (5) · 168-171

DOI: 10.15406/jpnc.2019.09.00401 ↗
AbstractBibliografische Angaben

Abstract

Kernicterus and severe jaundice are major contributors to neonatal morbidity in Nigeria, and they are commonly treated using invasive exchange blood transfusion (EBT) techniques. Total body phototherapy exposure (TBPE) is a new technique that avoids the risks of EBT and has been shown to be effective. The aim of this study was to evaluate the typical economic savings that result from the clinical success of the TBPE as provided by the Firefly® system in a Nigerian new-born centre. Severely jaundiced neonates who were treated using EBT between January 2017 and December 2017 were assessed as control cases. These neonates were compared to neonates who received TBPE using the Firefly® system (MTTS Asia, Hanoi Vietnam) as a first course intervention (test cases) after February 2018 onward. A total of 82 severely jaundiced new-borns qualified for inclusion, including 19 control cases and 63 test cases. All TBPE cases were successfully discharged, but two mortalities relating to EBT complications were recorded. The mean direct cost of treatment per patient was ₦94,553 (US$262) in the control group and ₦18,897 (US$52) in the test group. The mean patient burdens for other parameters (control: test) were bacterial infection burden (100% : 11%), human labour man-hours (9.8 : 1.2), and blood contamination burden (25% : 3%). The huge relative amount of savings recorded in this study has clearly demonstrated that Firefly® TBPE is an application that is both affordable and effective in a resource-constrained setting. Hence, we recommend its use in low- and middle-income countries.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →